Document:

Exhibit

EXHIBIT 10.2

FORM OF
RESTRICTED STOCK AGREEMENT

THIS AGREEMENT, dated as of __________, (“Grant Date”) is between MasterCard Incorporated, a Delaware Corporation (the “Company”), and you (the “Director”).  Capitalized terms that are used but not defined in this Agreement have the meanings given to them in the 2006 Non-Employee Director Equity Compensation Plan (“Plan”) and, where applicable, in the 2006 Long Term Incentive Plan (the “Omnibus Plan”), both as amended and restated as of June 5, 2012.
WHEREAS, the Company has established the Plan, the terms of which Plan, and, to the extent applicable, the Omnibus Plan (but not the standard terms and conditions of Section 8.4 thereof) are made a part hereof; 
WHEREAS, the Human Resources and Compensation Committee of the Board of Directors of the Company (the “Committee”) has approved, and the Board of Directors of the Company has ratified, this grant under the terms of the Plan;
NOW, THEREFORE, the parties hereby agree as follows:
1.    Award.
Subject to the terms and conditions of this Agreement and of the Plan, the Company hereby grants to the Director the number of shares of the Company’s $0.0001 par value Class A Common Stock (the “Common Shares”) reflected in the Director’s grant statement, the terms and conditions of which are incorporated as a part of this Agreement.  The Common Shares will be subject to the terms and conditions set forth below (the “Restricted Stock”).  Common Shares will be issued in the name of the Director, deposited in an account for the benefit of the Director, and subjected to appropriate transfer restrictions implemented to reflect the terms, conditions and restrictions applicable to the Restricted Stock as described herein.  
2.    Vesting.
The interest of the Director in the Restricted Stock is fully vested on grant, but is subject to transfer restrictions pursuant to Section 3 below.
3.    Transfer Restrictions.
The Restricted Stock granted hereunder may not be sold, assigned, margined, transferred, encumbered, conveyed, gifted, hypothecated, pledged, or otherwise disposed of and may not be subject to lien, garnishment, attachment or other legal process before the fourth anniversary of the Grant Date.  In the event the Director has a Termination from Service before the fourth anniversary of the Grant Date, the transfer restrictions shall lapse and be removed from the Common Shares within 60 days of the Director’s Termination from Service. 

1

4.    Stockholder Rights.
Except as otherwise provided in this Agreement, the Director will have, with respect to the Restricted Stock, all of the rights of a shareholder of the Company holding the class of Common Shares that is the subject of the Restricted Stock, including, if applicable, the right to vote the shares and the right to receive any cash dividends.
5.    Changes in Stock.
In the event of any change in the number and kind of outstanding stock by reason of any recapitalization, reorganization, merger, consolidation, stock split or any similar change affecting the Common Shares (other than a dividend payable in Common Shares) the Company shall make an appropriate adjustment in the number and terms of the Restricted Stock as provided in the Plan.  The adjustment provided under this Section 5 will be nondiscretionary and final and binding on all interested parties, including the affected Director and the Company; provided that the Committee will determine whether an adjustment is appropriate.
6.    Compliance with Law.
No Common Shares will be delivered to the Director under this Agreement unless counsel for the Company is satisfied that such delivery will be in compliance with all applicable laws, including, without limitation, any rule, regulation or procedure of the U.S. national securities exchange upon which the Common Shares are traded or any listing agreement with any such securities exchange, or any other requirement of law or of any administrative or regulatory body having jurisdiction over the Company.  The Company reserves the right to impose other requirements on the Restricted Stock, any Common Shares, and the Director's participation in the Plan, to the extent the Company determines, in its sole discretion that such other requirements are necessary or advisable to comply with applicable laws. Such requirements may include (but are not limited to) requiring the Director to sign any agreements or undertakings that may be necessary to accomplish the foregoing.
7.    Taxes.
The Director shall be liable for any and all U.S. and foreign income and social taxes, including any required withholding taxes, arising out of this Award.  To the extent withholding is required under applicable law, the Company is authorized to deduct from the total number of Common Shares the Director is to receive the total value equal to the amount necessary to satisfy any such withholding obligation at the minimum applicable withholding rate or, to the extent permitted by applicable accounting principles, at up to the maximum applicable withholding rate, or to obtain withholdings in any other method permitted by the Plan or the Omnibus Plan.  In accordance with U.S. federal income tax withholding requirements, the Company shall withhold on amounts payable to Directors who are considered U.S. nonresident aliens under Code Section 7701(b). 
8.    Discretionary Nature of Restricted Stock Award.
The Director acknowledges and agrees that the grant of Restricted Stock is a discretionary Alternative Award under Section 6.3 of the Plan.  The grant of Restricted Stock under the Plan is a one-time benefit and does not create any contractual or other right to receive a grant of Restricted Stock or other Alternative Award under the Plan in the future.  

2

9.    Data Authorization.
The Director acknowledges and consents to the collection, use, processing and transfer of personal data, in electronic or other form, as described in this paragraph.  The Company and its affiliates hold certain personal information about the Director, including the Director’s name, home address and telephone number, date of birth, social insurance number, remuneration, nationality, any shares of stock or directorships held in the Company, details of all Restricted Stock or any other entitlement to shares of stock awarded, canceled, purchased, vested, unvested or outstanding in the Director’s favor, for the purpose of managing and administering the Director's participation in the Plan (“Data”).  The Company and/or its affiliates will transfer Data amongst themselves as necessary for the purpose of implementation, administration and management of the Director’s participation in the Plan, and the Company and/or its affiliates may each further transfer Data to any third parties assisting the Company in the implementation, administration and management of the Plan.  These recipients may be located in the European Economic Area, or elsewhere, such as the United States.  The Director authorizes such third party recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing the Director’s participation in the Plan, including any requisite transfer of such Data as may be required for the administration of the Plan and/or the subsequent holding of shares of stock on the Director’s behalf to a broker or other third party with whom the Director may elect to deposit any shares of stock acquired pursuant to the Plan. This authorization is provided by the Director solely in connection with and for the purposes of implementation, administration and management of the Plan.  The Director may, at any time, review Data, require any necessary amendments to it, inquire about the safety measures taken to protect the Data, or withdraw the consents herein in writing by contacting the Company; however, withdrawing consent may affect the Director’s ability to participate in the Plan, but will not otherwise impact the Director's service with the Company.
10.    Miscellaneous.
(a)    The parties agree to execute such further instruments and to take such action as may reasonably be necessary to carry out the intent of this Agreement.
(b)    Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon delivery to the Director at the address then on file with the Company or upon delivery to the Company at 2000 Purchase Street, Purchase, New York 10577, Attn: Executive Vice President, Total Rewards.
(c)    This Agreement constitutes the entire agreement of the parties with respect to the subject matter hereof.

By __________________________
Name
Title

3Exhibit 4.2

 

THE SECURITIES REPRESENTED HEREBY HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND MAY NOT
BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE
STATE SECURITIES LAWS COVERING SUCH SECURITIES OR THE SALE IS MADE IN ACCORDANCE WITH AN EXEMPTION UNDER THE ACT AND ANY APPLICABLE
STATE SECURITIES LAWS, AND THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES REASONABLY SATISFACTORY
TO THE COMPANY STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS OF SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

 

Mustang Bio, Inc.

 

COMMON STOCK WARRANT

 

This Warrant is issued as of this ____ day of
______________ (the “Issue Date”) by Mustang Bio, Inc., a Delaware corporation (the “Company”),
to _____________________________, or permitted assigns (the “Holder”).

 

1. Issuance of Warrant;
Number and Type of Securities Subject to Warrant; Exercise Price. The Company hereby grants to the Holder the right to purchase
______________ shares of the Company’s Common Stock (the “Common Stock”). The exercise price of
the warrant will be $_____.

 

2. Term. This Warrant shall only be exercisable
in accordance with the terms of Section 6 hereof, and shall expire on the date that is ten (10) years after the Issue Date.

 

3. Adjustments and Notices. This Warrant
shall be subject to adjustment from time to time in accordance with the following provisions.

 

(a) Stock Splits, Subdivisions or Combinations.
If at any time on or after the date hereof the Company shall split, subdivide or otherwise change its outstanding shares of any
securities receivable upon exercise of this Warrant into a greater number of securities, the Warrant Price in effect immediately
prior to such subdivision shall thereby be proportionately reduced and the number of Warrant Shares shall thereby be proportionately
increased; and, conversely, if at any time on or after the date hereof the outstanding number of shares of any securities receivable
upon exercise of this Warrant shall be combined into a smaller number of securities, the Warrant Price in effect immediately prior
to such combination shall thereby be proportionately increased and the number of Warrant Shares shall thereby be proportionately
decreased, all subject to further adjustment as provided in this Section 3.

  

(b) Reclassification. If the Company, by
reclassification of securities, reorganization of the Company (or any other entity the securities of which are at the time receivable
upon the exercise of this Warrant) or otherwise (including by merger or consolidation), shall change any of the securities as to
which purchase rights under this Warrant exist into the same or a different number of securities of any other class or classes,
this Warrant shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as
the result of such change with respect to the securities that were subject to the purchase rights under this Warrant immediately
prior to such reclassification or other change and the Warrant Price therefor shall be appropriately adjusted, all subject to further
adjustment as provided in this Section 3.

 

(c) No Impairment. The Company shall not,
by amendment of its Certificate of Incorporation or Bylaws, each as amended to date, or through a reorganization, transfer of assets,
consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms to be observed or performed under this Warrant by the Company, but shall at all times in good
faith assist in carrying out the provisions of this Warrant and in taking all such action as may be necessary or appropriate to
protect the Holder’s rights under this Warrant against impairment.

 

(d) Fractional Shares. No fractional Warrant
Shares shall be issuable upon exercise or conversion of the Warrant and the number of Warrant Shares to be issued shall be rounded
to the nearest whole Warrant Share. If a fractional Warrant Share arises upon any exercise or conversion of the Warrant, the Company
shall eliminate such fractional Warrant Share by paying the Holder an amount computed by multiplying the fractional interest by
the fair market value of a full Warrant Share.

 

     

     

    

  

4. No Voting or Dividend Rights. Nothing
contained in this Warrant shall be construed as conferring upon the holder hereof the right to vote or to consent to receive notice
as a stockholder of the Company on any other matters or any rights whatsoever as a stockholder of the Company. No dividends or
interest shall be payable or accrued in respect of this Warrant or the interest represented hereby or the shares purchasable hereunder
until, and only to the extent that, this Warrant shall have been exercised.

 

5. Shares to be Fully Paid; Reservation of
Shares. The Company covenants and agrees that all Warrant Shares will, upon issuance and payment of the applicable Warrant
Price, be duly authorized, validly issued, fully paid and nonassessable, and free of all preemptive rights, liens and encumbrances,
except for restrictions on transfer provided for herein. The Company shall at all times reserve and keep available out of its authorized
and unissued Common Stock, solely for the purpose of providing for the exercise of the rights to purchase all Warrant Shares granted
pursuant to this Warrant, such number of shares of Common Stock as shall, from time to time, be sufficient therefor.

 

6. Exercise of Warrant. Subject to Section
4, this Warrant may be exercised in whole or in part, at any time, by the surrender of this Warrant, together with the Notice of
Exercise and Investment Representation Statement in substantially the forms attached hereto as Attachment 1 and Attachment
2, respectively (subject to appropriate revision if this Warrant is adjusted pursuant to Section 3 hereof), duly completed
and executed at the principal office of the Company, and accompanied by payment in full of the applicable aggregate Warrant Price
in cash or by check with respect to the Warrant Shares being purchased. Prior to exercise of the Warrant, the Holder shall notify
the Company of its desire to exercise the Warrant. This Warrant shall be deemed to have been exercised immediately prior to the
close of business on the date of its surrender for exercise as provided above, and the person or entity entitled to receive the
Warrant Shares issuable upon such exercise shall be treated for all purposes as holder of such shares of record as of the close
of business on such date.

 

7. Notice of Proposed Transfer. Prior
to any proposed transfer of this Warrant or the Warrant Shares received on the exercise of this Warrant (together, the “Securities”),
unless there is in effect a registration statement under the Securities Act of 1933, as amended (the “Act”)
covering the proposed transfer, the Holder thereof shall give written notice to the Company of such Holder’s intention to
effect such transfer. Each such notice shall describe the manner and circumstances of the proposed transfer in sufficient detail,
and shall, if the Company so requests, be accompanied (except in transactions in compliance with Rule 144) by either (i) an unqualified
written opinion of legal counsel who shall be reasonably satisfactory to the Company addressed to the Company and reasonably satisfactory
in form and substance to the Company’s counsel, to the effect that the proposed transfer of the Securities may be effected
without registration under the Act, or (ii) a “no action” letter from the Securities and Exchange Commission (the “Commission”)
to the effect that the transfer of such Securities without registration will not result in a recommendation by the staff of the
Commission that action be taken with respect thereto, whereupon the Holder of the Securities shall be entitled to transfer the
Securities in accordance with the terms of the notice delivered by the Holder to the Company; provided, however, no such
registration statement or opinion of counsel shall be necessary for a transfer by a Holder to any affiliate of such Holder. Each
certificate evidencing the Securities transferred as above provided shall bear the appropriate restrictive legend set forth above,
except that such certificate shall not bear such restrictive legend if in the opinion of counsel for the Company such legend is
not required in order to establish compliance with any provisions of the Act.

 

8. Certificate of Adjustment. Whenever
the Warrant Price or number or type of Warrant Shares issuable upon exercise of this Warrant is adjusted, as herein provided, the
Company shall promptly deliver to the record holder of this Warrant a certificate of the Secretary of the Company setting forth
the nature of such adjustment and a brief statement of the facts requiring such adjustment.

 

9. Replacement of Warrants. Upon receipt
by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of the Warrant,
and in the case of any such loss, theft or destruction of the Warrant, on delivery of an indemnity agreement or security reasonably
satisfactory in form and amount to the Company, and reimbursement to the Company of all reasonable expenses incidental thereto,
and upon surrender and cancellation of the Warrant if mutilated, the Company will execute and deliver, in lieu thereof, a new Warrant
of like tenor.

 

     

     

    

  

10. Amendment, Waiver, etc. Except as
expressly provided herein, neither this Warrant nor any term hereof may be amended, waived, discharged or terminated other than
by a written instrument signed by the party against whom enforcement of any such amendment, waiver, discharge or termination is
sought; provided, however, that any provisions hereof may be amended, waived, discharged or terminated upon the written
consent of the Company and a Requisite Majority. For purposes hereof, “Requisite Majority” shall mean
Holders of at least a majority of the Warrant Shares then issuable upon exercise of then outstanding warrants of like tenor to
this Warrant issued by the Company (the “Offering Warrants”); provided, however, that no
such amendment or waiver may disproportionately and adversely affect the Holder relative to the holders of all other Offering Warrants
without the Holder’s consent. Any amendment effected in accordance with this Section shall be binding upon all holders of
the Offering Warrants, each future holder of the Offering Warrants, and the Company. By acceptance hereof, the Holder acknowledges
that in the event the required consent is obtained, any term of this Warrant may be amended or waived with or without the consent
of the Holder.

 

11. Successors and Assigns. This Warrant
and the rights evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the successors
and assigns of the Holder. The provisions of this Warrant are intended to be for the benefit of all Holders from time to time of
this Warrant, and shall be enforceable by any such Holder.

 

12. Severability. In case any one or
more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt
in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor, and
upon so agreeing, shall incorporate such substitute provision in this Warrant.

 

13. Miscellaneous.
This Warrant shall be governed by the laws of the State of New York as such laws are applied to contracts to be entered into and
performed entirely in New York. The headings in this Warrant are for purposes of convenience and reference only, and shall not
be deemed to constitute a part hereof.

     

     

    

  

	ISSUED this ____ day of _____________.	 
	 	 
	 	Mustang Bio, Inc.
	 	 
	 	By: 	 	 
	 	Name:	 
	 	Title: 	 

 

     

     

    

 

Attachment 1

  

NOTICE OF EXERCISE

 

TO: Mustang Bio, Inc.

 

1. The undersigned hereby elects to purchase
_____________ shares of __________ of Mustang Bio, Inc. (the “Warrant Shares”) pursuant to the terms of the attached
Warrant, and tenders herewith payment of the purchase price in full, together with all applicable transfer taxes, if any.

 

2. Please issue a certificate or certificates
representing said number of Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

________________________________________

(Name)

_______________________________________

(Address)

	 	 	 	 
	 	 	 	 	 	 	 
	(Date)	 	(Name of Warrant Holder)
	 	 	 	 
	 	 	By:	 
	 	 	 	 
	 	 	Title:	 

 

     

     

    

 

Attachment 2

 

INVESTMENT REPRESENTATION STATEMENT

 

Shares of _________ of

Mustang Bio, Inc.

 

In connection with the purchase of the shares
of __________ of Mustang Bio, Inc. (the “Company”), the undersigned hereby represents to the Company as follows:

 

(A) The undersigned is an accredited investor
(as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Act”)). The
undersigned acknowledges that an investment in the Company is highly speculative and represents that it is able to fend for itself
in the transactions contemplated by this Statement, has such knowledge and experience in financial and business matters as to be
capable of evaluating the merits and risks of its investments, and has the ability to bear the economic risks (including the risk
of a total loss) of its investment. The undersigned represents that it has had the opportunity to ask questions of the Company
concerning the Company’s business and assets and to obtain any additional information which it considered necessary to verify
the accuracy of or to amplify the Company’s disclosures, and has had all questions which have been asked by it satisfactorily
answered by the Company.

 

(B) The undersigned understands that no liquid
public market now exists for the securities being issued by the Company and that the Company has made no assurances that a public
market will ever exist for the Company’s securities being obtained hereby.

 

(C) The undersigned understands that the securities
issued upon exercise of the Warrant (the “Securities”), and any securities issued in respect thereof or exchange therefor,
may bear the following legend:

 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES LAWS, AND
MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY
APPLICABLE STATE SECURITIES LAWS COVERING SUCH SECURITIES OR THE SALE IS MADE IN ACCORDANCE WITH AN EXEMPTION UNDER THE ACT AND
ANY APPLICABLE STATE SECURITIES LAWS, AND THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES REASONABLY
SATISFACTORY TO THE COMPANY STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS
DELIVERY REQUIREMENTS OF SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAWS.”

 

(D) By executing this Statement, the undersigned
further represents that it does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer
or grant participation to such person or to any third person, with respect to any Securities issuable upon exercise of the Warrant. 

 

(E) The undersigned understands that the Securities
issuable upon exercise of the Warrant at the time of issuance and exercise may not be registered under the Act, and applicable
state securities laws, on the ground that the issuance of such securities is exempt pursuant to Section 4(2) of the Act and state
law exemptions relating to offers and sales not by means of a public offering, and that the Company’s reliance on such exemptions
is predicated on the undersigned’s representations set forth herein.

 

(F) The undersigned agrees that in no event
will it make a disposition of any Securities acquired upon the exercise of the Warrant unless and until (i) it shall have notified
the Company of the proposed disposition and shall have furnished the Company with a statement of the circumstances surrounding
the proposed disposition, and (ii) if reasonably required by the Company it shall have furnished the Company with an opinion of
counsel reasonably satisfactory to the Company and Company’s counsel to the effect that (A) appropriate action necessary
for compliance with the Act and any applicable state securities laws has been taken or an exemption from the registration requirements
of the Act and such laws is available, and (B) the proposed transfer will not violate any of said laws.

 

(G) The undersigned acknowledges that the Securities
issuable upon exercise of the Warrant must be held indefinitely unless subsequently registered under the Act or an exemption from
such registration is available. The undersigned is aware of the provisions of Rule 144 promulgated under the Act which permit limited
resale of shares purchased in a private placement subject to the satisfaction of certain conditions, including, among other things,
the existence of a public market for the shares, the availability of certain current public information about the Company, the
resale occurring not less than one year after a party has purchased and paid for the security to be sold, the sale being through
a “broker’s transaction” or in transactions directly with a “market makers” (as provided by Rule
144(f)) and the number of shares being sold during any three-month period not exceeding specified limitations.

 

[Signature on Next Page]

 

     

     

    

  

	Dated:	 	 	 
	 	 	 	 
	 	 	 	 
	(Print Name of Holder)	 
	 	 	 	 
	By:	 	 	 	 
	 	(signature)	 
	 	 	 	 
	Name:	 	 	 
	 	(print name of person signing)	 
	 	 	 	 
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}]]